FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033997645> ?p ?o ?g. }

• W2033997645 endingPage "208" @default.
• W2033997645 startingPage "200" @default.
• W2033997645 abstract "Objective To provide program methodology and outcomes data identifying the impact of clinical pharmacy services (CPSs) in patients with type 2 diabetes. Design Longitudinal pre–post cohort study. Setting Regional primary care group in Buffalo, NY, during 2006–2007. Patients Patients with type 2 diabetes identified by their primary care providers were referred to the MedSense program; a pharmacist-led, patient-centered pharmacotherapy management program developed through university collaboration with a regional primary care physician group. Interventions Education, clinical assessments, provider recommendations, and longitudinal follow-up of treatment goals provided by MedSense pharmacists. Main outcome measures Clinical outcomes were followed for 1 year from the index date for primary diabetes endpoints (glycosylated hemoglobin and fasting plasma glucose) and accompanying metabolic parameters (body mass index, blood pressure, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides). Economic endpoints from the payer perspective were also followed for 1 year from the index date for medical and prescription-related costs. Results Primary diabetes endpoints were significantly reduced versus baseline at the 6-month (−1.1%; P < 0.0001, −39 mg/dL; P = 0.003) and 12-month (−1.1%; P < 0.0001, −35 mg/dL; P = 0.005) assessments. Improvement rates were observed for all accompanying metabolic parameters at each assessment (range 40–64%). Geometric mean costs tended to decrease versus baseline at 6-month (−$84; P = 0.785) and 12-month (−$216; P = 0.414) assessments, despite nominal increases in diabetes and total medication costs. Conclusion In this CPS model, there were initial and sustained reductions in the primary diabetes endpoints and a high rate of improvement for accompanying metabolic parameters. Concurrent with clinical improvements, total direct medical costs were reduced despite an increase in antidiabetic medication and total medication costs. To provide program methodology and outcomes data identifying the impact of clinical pharmacy services (CPSs) in patients with type 2 diabetes. Longitudinal pre–post cohort study. Regional primary care group in Buffalo, NY, during 2006–2007. Patients with type 2 diabetes identified by their primary care providers were referred to the MedSense program; a pharmacist-led, patient-centered pharmacotherapy management program developed through university collaboration with a regional primary care physician group. Education, clinical assessments, provider recommendations, and longitudinal follow-up of treatment goals provided by MedSense pharmacists. Clinical outcomes were followed for 1 year from the index date for primary diabetes endpoints (glycosylated hemoglobin and fasting plasma glucose) and accompanying metabolic parameters (body mass index, blood pressure, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides). Economic endpoints from the payer perspective were also followed for 1 year from the index date for medical and prescription-related costs. Primary diabetes endpoints were significantly reduced versus baseline at the 6-month (−1.1%; P < 0.0001, −39 mg/dL; P = 0.003) and 12-month (−1.1%; P < 0.0001, −35 mg/dL; P = 0.005) assessments. Improvement rates were observed for all accompanying metabolic parameters at each assessment (range 40–64%). Geometric mean costs tended to decrease versus baseline at 6-month (−$84; P = 0.785) and 12-month (−$216; P = 0.414) assessments, despite nominal increases in diabetes and total medication costs. In this CPS model, there were initial and sustained reductions in the primary diabetes endpoints and a high rate of improvement for accompanying metabolic parameters. Concurrent with clinical improvements, total direct medical costs were reduced despite an increase in antidiabetic medication and total medication costs." @default.
• W2033997645 created "2016-06-24" @default.
• W2033997645 creator A5011906527 @default.
• W2033997645 creator A5017176064 @default.
• W2033997645 creator A5032766296 @default.
• W2033997645 creator A5050273468 @default.
• W2033997645 creator A5085921973 @default.
• W2033997645 creator A5090898735 @default.
• W2033997645 date "2009-03-01" @default.
• W2033997645 modified "2023-10-10" @default.
• W2033997645 title "Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care–based collaboration model" @default.
• W2033997645 cites W172609984 @default.
• W2033997645 cites W1752045965 @default.
• W2033997645 cites W1967565046 @default.
• W2033997645 cites W1980846619 @default.
• W2033997645 cites W1981266447 @default.
• W2033997645 cites W1997430032 @default.
• W2033997645 cites W2002093221 @default.
• W2033997645 cites W2014958049 @default.
• W2033997645 cites W2026252037 @default.
• W2033997645 cites W2027784966 @default.
• W2033997645 cites W2028411331 @default.
• W2033997645 cites W2046645679 @default.
• W2033997645 cites W2055886342 @default.
• W2033997645 cites W2059266698 @default.
• W2033997645 cites W2082346117 @default.
• W2033997645 cites W2096778268 @default.
• W2033997645 cites W2097403464 @default.
• W2033997645 cites W2102711579 @default.
• W2033997645 cites W2120108665 @default.
• W2033997645 cites W2136584816 @default.
• W2033997645 cites W2146133486 @default.
• W2033997645 cites W2163302849 @default.
• W2033997645 cites W2186147562 @default.
• W2033997645 cites W2189439872 @default.
• W2033997645 cites W2337454357 @default.
• W2033997645 cites W2769264260 @default.
• W2033997645 doi "https://doi.org/10.1331/japha.2009.08160" @default.
• W2033997645 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19289346" @default.
• W2033997645 hasPublicationYear "2009" @default.
• W2033997645 type Work @default.
• W2033997645 sameAs 2033997645 @default.
• W2033997645 citedByCount "33" @default.
• W2033997645 countsByYear W20339976452012 @default.
• W2033997645 countsByYear W20339976452013 @default.
• W2033997645 countsByYear W20339976452014 @default.
• W2033997645 countsByYear W20339976452015 @default.
• W2033997645 countsByYear W20339976452016 @default.
• W2033997645 countsByYear W20339976452017 @default.
• W2033997645 countsByYear W20339976452018 @default.
• W2033997645 countsByYear W20339976452021 @default.
• W2033997645 countsByYear W20339976452022 @default.
• W2033997645 countsByYear W20339976452023 @default.
• W2033997645 crossrefType "journal-article" @default.
• W2033997645 hasAuthorship W2033997645A5011906527 @default.
• W2033997645 hasAuthorship W2033997645A5017176064 @default.
• W2033997645 hasAuthorship W2033997645A5032766296 @default.
• W2033997645 hasAuthorship W2033997645A5050273468 @default.
• W2033997645 hasAuthorship W2033997645A5085921973 @default.
• W2033997645 hasAuthorship W2033997645A5090898735 @default.
• W2033997645 hasConcept C10446079 @default.
• W2033997645 hasConcept C104863432 @default.
• W2033997645 hasConcept C126322002 @default.
• W2033997645 hasConcept C134018914 @default.
• W2033997645 hasConcept C159110408 @default.
• W2033997645 hasConcept C194828623 @default.
• W2033997645 hasConcept C203092338 @default.
• W2033997645 hasConcept C2426938 @default.
• W2033997645 hasConcept C27415008 @default.
• W2033997645 hasConcept C2777180221 @default.
• W2033997645 hasConcept C2779457091 @default.
• W2033997645 hasConcept C2780221984 @default.
• W2033997645 hasConcept C2780670349 @default.
• W2033997645 hasConcept C2984752397 @default.
• W2033997645 hasConcept C500440147 @default.
• W2033997645 hasConcept C512399662 @default.
• W2033997645 hasConcept C535046627 @default.
• W2033997645 hasConcept C555293320 @default.
• W2033997645 hasConcept C71924100 @default.
• W2033997645 hasConceptScore W2033997645C10446079 @default.
• W2033997645 hasConceptScore W2033997645C104863432 @default.
• W2033997645 hasConceptScore W2033997645C126322002 @default.
• W2033997645 hasConceptScore W2033997645C134018914 @default.
• W2033997645 hasConceptScore W2033997645C159110408 @default.
• W2033997645 hasConceptScore W2033997645C194828623 @default.
• W2033997645 hasConceptScore W2033997645C203092338 @default.
• W2033997645 hasConceptScore W2033997645C2426938 @default.
• W2033997645 hasConceptScore W2033997645C27415008 @default.
• W2033997645 hasConceptScore W2033997645C2777180221 @default.
• W2033997645 hasConceptScore W2033997645C2779457091 @default.
• W2033997645 hasConceptScore W2033997645C2780221984 @default.
• W2033997645 hasConceptScore W2033997645C2780670349 @default.
• W2033997645 hasConceptScore W2033997645C2984752397 @default.
• W2033997645 hasConceptScore W2033997645C500440147 @default.
• W2033997645 hasConceptScore W2033997645C512399662 @default.
• W2033997645 hasConceptScore W2033997645C535046627 @default.
• W2033997645 hasConceptScore W2033997645C555293320 @default.
• W2033997645 hasConceptScore W2033997645C71924100 @default.

• next